SHARE SUBSCRIPTION AGREEMENT
BY AND AMONG
UNITED HOMES GROUP, INC.,
AND
CONVERSANT OPPORTUNITY MASTER FUND LP
DATED AS OF MARCH 30, 2023
TABLE OF CONTENTS
Page
|
ARTICLE I. SUBSCRIPTION FOR AND SALE OF SHARES
|
1 |
|
|
Section 1.1 |
Subscription for and Sale of Shares |
1 |
|
|
Section 1.2 |
Closing |
1 |
|
|
Section 1.3 |
Lock-up |
1 |
|
|
Section 1.4 |
Permitted Transferees |
2 |
|
|
Section 1.5 |
Change of Control |
2 |
|
|
|
|
|
|
ARTICLE II. REPRESENTATIONS AND WARRANTIES OF THE ISSUER
|
2 |
|
|
Section 2.1 |
Organization and Qualification |
2 |
|
|
Section 2.2 |
Authority. |
2 |
|
|
Section 2.3 |
Consents and Requisite Governmental Approvals; No Violations. |
3 |
|
|
|
|
|
ARTICLE III. REPRESENTATIONS AND WARRANTIES OF THE CONVERSANT INVESTOR
|
3 |
|
|
Section 3.1
|
Authorization
|
3 |
|
|
Section 3.2
|
Purchase Entirely for Own Account |
3 |
| |
Section 3.3
|
Accredited Investor |
4 |
| |
|
|
|
|
ARTICLE IV. BOARD AND COMMITTEE MATTERS
|
4 |
| |
Section 4.1
|
Board Matters. |
4 |
| |
Section 4.2
|
Committees of the Board of Directors |
5 |
| |
|
|
|
|
ARTICLE V. CERTAIN AGREEMENTS AMONG THE PARTIES
|
5 |
| |
Section 5.1
|
Preemptive Rights |
5 |
| |
Section 5.2
|
Conversant Investor Consent Rights |
7 |
| |
Section 5.3
|
Information Rights |
9 |
| |
Section 5.4
|
No Shorting; No Manipulation |
9 |
| |
|
|
|
|
ARTICLE VI. MISCELLANEOUS
|
10 |
| |
Section 6.1 |
Term and Termination |
10 |
| |
Section 6.2 |
Assignment |
10 |
| |
Section 6.3 |
Successors and Assigns |
10 |
| |
Section 6.4 |
Governing Law |
11 |
| |
Section 6.5 |
Counterparts |
11 |
| |
Section 6.6 |
Titles and Subtitles |
11 |
| |
Section 6.7 |
Notices |
11 |
| |
Section 6.8 |
Amendments and Waivers |
12 |
| |
Section 6.9 |
Severability |
12 |
| |
Section 6.10 |
Delays or Omissions |
12 |
| |
Section 6.11 |
Entire Agreement |
13 |
| |
Section 6.12 |
Further Assurances |
13 |
| |
Section 6.13 |
Jurisdiction and Venue; Waiver of Jury Trial |
13 |
| |
Section 6.14 |
Interpretation |
13 |
SUBSCRIPTION AGREEMENT
This SUBSCRIPTION AGREEMENT (this “Agreement”) is dated as of March 30, 2023, by and among (a) United Homes Group, Inc., a Delaware corporation (the “Issuer”)
and (b) Conversant Opportunity Master Fund LP, a Cayman Islands exempted limited partnership (the “Conversant Investor”).
WHEREAS, the Issuer, the Conversant Investor, and the other Investors (as defined therein) party thereto are party to that certain Convertible Note Purchase
Agreement (the “Note Purchase Agreement”), dated as of March 21, 2023, pursuant to which the Investors agreed, subject to the terms and conditions thereof, to purchase from the Issuer and the Issuer agreed to issue and sell to the Investors
the Convertible Notes. Capitalized terms used but not otherwise defined herein shall have the meanings given to them in the Note Purchase Agreement; and
WHEREAS, as consideration for the Conversant Investor’s purchase of the Convertible Notes, the Issuer wishes to sell, and the Conversant Investor wishes to
subscribe for, 535,173 Issuer Class A Shares (the “Shares”).
NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties to this Agreement hereby agree as follows:
ARTICLE I.
SUBSCRIPTION FOR AND SALE OF SHARES
Section 1.1 Subscription for and Sale of Shares. Upon the terms and subject to the conditions set forth herein, at
the Closing (which shall take place on the Closing Date) the Issuer shall issue to the Conversant Investor the Shares concurrently with the Issuer’s sale of the Convertible Notes to the Conversant Investor. No additional consideration shall be paid
by the Conversant Investor for the Shares; provided, that the Issuer and the Conversant Investor (and any assignee of either) agree that the Shares shall be treated as having been issued for $5.00 per Share for U.S. federal, state and local
income tax purposes, including for purposes of determining the aggregate “original issue discount” on the Convertible Notes pursuant to Section 1271-1275 of the Code.
Section 1.2 Closing. At the Closing, the Issuer shall provide the Conversant Investor with evidence that the Shares have
been recorded in book-entry form on the Company’s register of stockholders maintained by its transfer agent, American Stock Transfer & Trust Company, LLC in the Conversant Investor’s or its nominee’s name.
Section 1.3 Lock-up. Except as permitted by Section 1.4 and Section 1.5, the Conversant Investor shall not (a) lend,
offer, pledge, hypothecate, encumber, donate, assign, sell, contract to sell, sell any option, or contract to purchase, purchase any option, or contract to sell, grant any option, right, or warrant to purchase, or otherwise transfer or dispose of,
directly or indirectly, any Shares, (b) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Shares, or (c) publicly disclose the intention to do any of the
foregoing, whether any such transaction described in clauses (a), (b), or (c) above is to be settled by delivery of Shares or other securities, in cash or otherwise (any of the foregoing
described in clauses (a), (b), or (c), a “Prohibited Transfer”), prior to the first anniversary of the Closing Date (the “Lock-up
Period”).
Section 1.4 Permitted Transferees. The provisions of Section 1.3 shall not apply to the transfer of any or all of the
Shares (a) to any Permitted Transferee, (b) by virtue of laws of descent and distribution upon the death of an individual and (c) pursuant to a court order or settlement agreement related to the distribution of assets in connection with the
dissolution of marriage or civil union; provided, however, that in either of cases (a), (b) or (c), it shall be a condition to such transfer that such transfer complies with the Securities Act and other applicable law, and that the transferee
executes and delivers to the Issuer an agreement stating that the transferee is receiving and holding the Shares subject to the provisions of this Agreement applicable to the Conversant Investor, and there shall be no further transfer of such
Shares except in accordance with this Agreement. As used in this Agreement, the term “Permitted Transferee” shall mean: (i) the members of the Conversant Investor’s immediate family (for purposes of this Agreement, “immediate family” shall
mean with respect to any natural person, any of the following: such person’s spouse or domestic partner, the siblings of such person, and the direct descendants and ascendants (including adopted and step children and parents) of such person),
(ii) any trust solely for the direct or indirect benefit of the Conversant Investor or the immediate family of the Conversant Investor, (iii) if the Conversant Investor is a trust, to the trustor or beneficiary of such trust or to the estate of a
beneficiary of such trust, (iv) if the Conversant Investor is an entity, officers, directors, general partners, limited partners, members, or stockholders of such entity that receive such transfer as a distribution, or related investment funds or
vehicles controlled or managed by such persons or their respective Affiliates, (v) any Affiliate of the Conversant Investor, or (vi) any other Investor. The Conversant Investor further agrees to execute such agreements as may be reasonably
requested by the Issuer that are consistent with the foregoing or that are necessary to give further effect thereto.
Section 1.5 Change of Control. The provisions of Section 1.3 shall not apply to any transfer by the Conversant Investor pursuant to a Change of Control Transaction of the Issuer.
ARTICLE II.
REPRESENTATIONS AND WARRANTIES OF THE ISSUER
Section 2.1 Organization and
Qualification. The Issuer is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Delaware.
Section 2.2 Authority.
(a) The Issuer
has the requisite corporate power and authority to execute and deliver this Agreement and the Shares and to consummate the transactions contemplated hereby. The execution and delivery of this Agreement and the issuance of the Shares and the
consummation of the transactions contemplated hereby have been duly authorized by all necessary corporate action on the part of the Issuer. This Agreement has been duly and validly executed and delivered by the Issuer and constitutes a valid, legal
and binding agreement of the Issuer (assuming this Agreement has been duly authorized, executed and delivered by the other Persons party hereto or thereto, as applicable), enforceable against the Issuer in accordance with their terms (subject to
the Bankruptcy and Equity Exception.
(b) The
issuance of the Shares has been duly authorized by all necessary corporate action. When issued in accordance with the terms of this Agreement, the Shares shall be validly issued, fully paid and non-assessable and shall not give rise to preemptive
rights or other rights of stockholders of the Issuer.
Section 2.3 Consents and Requisite Governmental Approvals; No Violations.
(a) No Consent
of, with or to be made to any Governmental Entity is required on the part of the Issuer with respect to the Issuer’s execution, delivery or performance of its applicable obligations under this Agreement or the consummation of the transactions
contemplated by this Agreement, except for (i) the filing with the SEC of such reports under Section 13(a) or 15(d) of the Exchange Act as may be required in connection with this Agreement or the transactions contemplated hereby, (ii) such filings
with and approvals of Nasdaq to permit the Shares to be issued in connection with the transactions contemplated by this Agreement to be listed on Nasdaq, (iii) the filing of the Issuer A&R Certificate of Incorporation with and acceptance
thereof by the Delaware Secretary of State, (iv) the Issuer Stockholder Approval and the Nasdaq Approval or (v) any other consents, approvals, authorizations, designations, declarations, waivers or filings, the absence of which would not have an
Issuer Material Adverse Effect.
(b) None of the
execution, delivery or performance by the Issuer of this Agreement, or the consummation by the Issuer of the transactions contemplated hereby, will, directly or indirectly (with or without due notice or lapse of time or both) (i) result in any
breach of any provision of the Governing Documents of the Issuer, (ii) result in a violation or breach of, or constitute a default or give rise to any right of termination, cancellation, amendment, modification, suspension, revocation or
acceleration under, any of the terms, conditions or provisions of any Contract to which the Issuer is a party, (iii) violate, or constitute a breach under, any Order or applicable Law to which the Issuer or any of its properties or assets are bound
or (iv) result in the creation of any Lien upon any of the assets or properties (other than any Permitted Liens) of the Issuer, except in the case of clauses (ii) through (iv) above, as would not have an Issuer Material Adverse Effect.
ARTICLE III.
REPRESENTATIONS AND WARRANTIES OF THE CONVERSANT INVESTOR
Section 3.1 Authorization. The Conversant Investor has full power and authority to enter into this Agreement. This
Agreement, when executed and delivered by the Conversant Investor, will constitute valid and legally binding obligations of the Conversant Investor, enforceable in accordance with their terms, except as limited by the Bankruptcy and Equity
Exception. No Consent or order of, or registration, qualification, designation, declaration or filing with any federal, state or local Governmental Entity is required on the part of the Conversant Investor in connection with the consummation of the
transactions contemplated by this Agreement.
Section 3.2 Purchase Entirely for Own Account. This Agreement is made by the Conversant Investor in reliance upon the
Conversant Investor’s representation to the Issuer, which the Conversant Investor confirms by its execution of this Agreement, that the Shares will be acquired for investment for the Conversant Investor’s own account, not as a nominee or agent. The
Conversant Investor (a) is not acquiring the Shares with a view to the resale or distribution of any
part thereof and (b) does not have the present intention of selling, granting any participation in, or otherwise distributing the Shares, in
each case of clause (a) and (b), in violation of the Securities Act. By executing this Agreement, the Conversant Investor further represents that it does not presently have any Contract with any Person to sell, transfer or grant participations to
such person or to any third person, with respect to any of the Shares.
Section 3.3 Accredited Investor. The Conversant Investor is an accredited investor as defined in Rule 501(a) of Regulation
D promulgated under the Securities Act and shall submit to the Issuer such further assurances of such status as may be reasonably requested by the Issuer.
ARTICLE IV.
BOARD AND COMMITTEE MATTERS
Section 4.1 Board Matters.
(a) For as long
as fifty percent (50%) of the original principal amount of the Convertible Notes are outstanding and have not been converted or cash settled, the Conversant Investor shall have the right to designate one (1) member of the Board of Directors, who
shall initially be Robert Grove.
(b) For so long
as the Conversant Investor holds the right to designate at least one member of the Board of Directors pursuant to this Article IV (such designee, the “Conversant Board Representative”), the Issuer shall cause the Conversant Board
Representative to be elected or appointed to the Board of Directors, including by taking all action as may be necessary to secure the favorable votes of the Board of Directors or the stockholders of the Issuer, as applicable, in respect of the
election or appointment such Conversant Board Representative at the time of any future director elections or appointments (including to fill any vacancy), whether at any annual or special meeting of the Board of Directors or stockholders or
pursuant to any written consent of the Board of Directors or stockholders of the Issuer or, to the extent necessary, by expanding the size of the Board of Directors and appointing the Conversant Board Representative to the Board of Directors (and,
to the extent necessary, calling a special meeting of the Issuer’s stockholders for the purpose of amending the Issuer’s Certificate of Incorporation to allow such expansion). Promptly following the Closing Date, and in any event within five (5)
Business Days thereof, the Issuer shall cause Robert Grove to be elected or appointed to the Board of Directors as a Class III director (i.e., a member of the class of directors whose term of office expires at the Issuer’s annual meeting of
stockholders to be held in 2026).
(c) For so long as the Conversant
Investor holds the right to designate a member of the Board of Directors, the Issuer shall not, without the prior written approval of the Conversant Board Representative:
(i) increase the size of the Board of Directors in excess of eleven (11) members; or
(ii) decrease the size of the Board of Directors (A) to fewer than eleven (11) members, or (B) if such decrease would require the resignation of the Conversant Board Representative from the
Board of Directors.
(d) The Issuer
will reimburse the Conversant Board Representative for its reasonable and documented out-of-pocket expenses incurred in connection with travel to or from and attendance at each meeting of the Board of Directors. The Conversant Board Representative
will receive the same director compensation as each other non-executive director of the Board of Directors.
(e) For so long
as the Conversant Investor holds the right to designate a member of the Issuer Board of Directors, in the event that a vacancy is created at any time by the death, disability, retirement, resignation or removal of the Conversant Board
Representative, the Conversant Investor (and only the Conversant Investor) may designate another individual to be elected to fill the vacancy created thereby, and the Issuer hereby agrees to take, at any time and from time to time, all actions
necessary to accomplish the same.
(f) If the
Issuer reasonably determines that the Conversant Board Representative is subject to any of the “bad actor” disqualifications (“Disqualification Events”) described in Rule 506(d)(1)(i) through (viii) under the Securities Act, the Conversant
Board Representative shall not be eligible for appointment to the Board of Directors. To the Conversant Investor’s knowledge, Robert Grove is not subject to a Disqualification Event.
Section 4.2 Committees of the Board of Directors. For so long as the Conversant Investor holds the right to designate at
least one Conversant Board Representative, the Conversant Investor shall have the right to designate one (1) member of each committee of the Board of Directors that may be established from the Board of Directors from time to time.
ARTICLE V.
CERTAIN AGREEMENTS AMONG THE PARTIES
Section 5.1 Preemptive Rights.
(a) Subject to the terms and conditions of this Section 5.1 and applicable Securities Laws, from and after the Closing Date until such time as no Convertible Notes remain outstanding, if any Issuer Group Entity issues, sells, or authorizes the
sale of any New Securities other than to the Issuer or a wholly-owned Issuer Group Entity (a “New Securities Issuance”), the Issuer shall offer a portion of such New Securities (and if more than one class of securities is included in the New
Securities, then a portion of the amount of each such class of securities included in the New Securities) to the Conversant Investor equal to the portion of the outstanding Issuer Shares that the Conversant Investor holds at such time, but before
giving effect to such New Securities Issuance (such portion, the Conversant Investor’s “Equity Share”).
(b) The Issuer
shall give prompt written notice (but in no event later than fifteen (15) Business Days prior to the issuance of any New Securities in the applicable New Securities Issuance) to the Conversant Investor, setting forth the type and estimated number
(which may be a range) of such New Securities to be issued, the estimated price per New Security (which may be a range), the estimated issuance date, and all of the other material terms and conditions of such issuance to the extent then known by
the Issuer (the “Initial Offer Notice”). The Issuer shall provide the Conversant Investor with written notice of the final terms of the issuance of such New Securities described in the Initial Offer Notice on or prior to the fifth (5th)
Business Day prior to
the issuance of such New Securities (the “Final Offer Notice”).
(c) By
notification to the Issuer (an “Election Notice”) within fifteen (15) Business Days after the Final Offer Notice is given, the Conversant Investor may elect to purchase or otherwise acquire a number of New Securities up to its Equity Share,
at the price and on the terms specified in the Final Offer Notice. On and after the issuance date set forth in the Final Offer Notice, the Issuer shall be permitted to proceed with the closing of the sale of such New Securities to the applicable
third party(ies); provided, that if such closing has not occurred within thirty (30) days following the issuance date set forth in the Final Offer Notice (it being agreed that the Conversant Investor making an election to purchase New
Securities in response to a Final Offer Notice providing a range for the estimated number of New Securities or estimated range of price per New Security may proffer an election that is conditioned upon, or limited by, the actual price per New
Security or actual number of New Securities, in each case, to be issued), the Issuer shall be required to again comply with the procedures set forth in this Section 5.1 as though such New Securities Issuance were a new New Securities Issuance.
(d) If the
Conversant Investor exercises its preemptive rights hereunder with respect to such New Securities Issuance, the Issuer shall (or shall cause such Subsidiary to) issue to the Conversant Investor (or its designated Affiliate(s)) the number of
securities specified in the Conversant Investor’s Election Notice promptly thereafter; provided, that if the Conversant Investor shall have so notified the Issuer at least three (3) Business Days prior to the issuance date set forth in the
Final Offer Notice, such purchase and sale shall occur on the same date as, or substantially concurrently with, the New Securities Issuance.
(e) The
election by the Conversant Investor not to exercise its preemptive rights hereunder in any one instance shall not affect its rights with respect to future New Securities Issuances.
(f) Notwithstanding anything to the contrary in this Agreement, in the event that the Conversant Investor exercises its preemptive rights pursuant to this Section 5.1 and the purchase or issuance of such New Securities would require the
applicable Issuer Group Entity to obtain approval of its stockholders pursuant to the listing rules of Nasdaq or such national securities exchange upon which such New Securities are listed, if any, then the applicable Issuer Group Entity and the
Conversant Investor will use their respective commercially reasonable efforts to negotiate the terms of any such transaction in good faith, including, without limitation, the terms of any New Securities issued pursuant to such transaction to the
Conversant Investor, such that the issuance to the Conversant Investor would not require such stockholder approval while providing the Conversant Investor and/or its Affiliates with substantially similar benefits and rights of such securities
issued in the New Securities Issuance.
(g) Notwithstanding Section 5.1(a) to Section 5.1(f), if the Board of Directors of the Issuer reasonably determines that it is necessary or advisable to issue securities of such Issuer Group Entity that would otherwise be required to be offered
to the Conversant Investor under this Section 5.1 prior to their issuance, such Issuer Group Entity may issue such securities without first complying with this Section 5.1; provided, that within thirty (30) days after such issuance, such
Issuer Group Entity offers the Conversant Investor the opportunity to purchase the number of such Equity Securities that the Conversant Investor would be entitled to purchase
pursuant to this Section 5.1 by sending written notice to the Conversant Investor, which notice shall contain the information
required in the Initial Offer Notice. In the event of an offer made by any Issuer Group Entity pursuant to this Section 5.1(g), the timing and procedures for the exercise period and closing of such offer shall be the same as those set forth in
Section 5.1(a) to Section 5.1(f), with appropriate modifications to reflect the post-issuance delivery of the notice as contemplated by this Section 5.1(g).
Section 5.2 Conversant Investor Consent Rights. During the term of this Agreement, the Issuer shall not, and shall cause
each other Issuer Group Entity not to, without first obtaining the consent in writing of the Conversant Investor:
(a) materially
change the principal business of the Issuer Group Entities taken as a whole, enter into new lines of business or exit the Issuer Group Entities’ current line of business;
(b) enter into
an agreement with respect to (or otherwise consummate) a Change of Control Transaction involving the Issuer;
(c) consummate
any voluntary or involuntary liquidation, dissolution or winding up of the affairs of any Issuer Group Entity under any Debtor Relief Laws or file a petition under Bankruptcy Law;
(d) change the
Governing Documents or capital structure of any Issuer Group Entity in a manner that adversely affects the Conversant Investor;
(e) authorize,
create, classify, reclassify or issue any class or series of Equity Securities or other capital stock of the Issuer that expressly provides that, or has the effect that, such class or series ranks senior to the Shares with respect to rights to
payment of dividends or distributions or rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Issuer;
(f) incur or guaranty any
Indebtedness, other than Indebtedness:
(i) incurred pursuant to that certain credit agreement by and among Great Southern Homes, Inc., the financial institutions party
thereto, and Wells Fargo Bank, National Association, as administrative agent, dated as of July 9, 2021, as amended through the date of this Agreement (the “
Current Credit Agreement”);
or
(ii) incurred pursuant to any line of credit similar to the Current Credit Agreement (including by reason of, among other similar characteristics and features, having an asset-based availability of total loan funding available at any
time where the asset upon which loan funding availability is calculated – i.e., the borrowing base - is real property interests) and utilized for financing the operation of the Issuer’s business, including any such Indebtedness assumed in
connection with any Issuer Group Entity’s acquisition of or investment in another company or business, so long as (A) the amount outstanding under any such similar line of credit cannot, at any time, exceed a ratio of Indebtedness to
stockholders equity of the
Issuer and the Issuer Group Entities on consolidated basis of 2.5 to 1 for the period from the date of this Agreement through December 31, 2023 and 2.25 to 1 thereafter regardless of whether the Current Credit Agreement has
been amended or replaced, in each case and (B) in the case of any line of credit entered into in addition to the Current Credit Agreement, such line of credit shall not permit the aggregate value of the total borrowing base thereunder that is
attributable to “Speculative Housing Units” and “Model Housing Units” (as each of the foregoing terms is defined in the Current Credit Agreement) to exceed 70% of the aggregate value of the total borrowing base and excludes any value of
“Speculative Housing Units” and “Model Housing Units” in excess of the 70% limitation from the calculation of the aggregate value of the total borrowing base;
(g) pay or
agree to pay any dividend, distribution, loan, advance, guaranty, extension of credit or other payment (whether in cash, securities or other property) to or for the benefit of any Person (other than a wholly owned Subsidiary of the Issuer) that
holds any Equity Securities in any Issuer Group Entity, whether or not such interest is evidenced by a security, and any other payment, whether in cash, securities or other property, on account of the purchase, redemption, retirement, acquisition,
cancellation or termination of any capital stock of any Issuer Group Entity, whether now or hereafter outstanding, or of any options, warrants or similar rights to purchase such capital stock or any security convertible into or exchangeable for
such capital stock except for the repurchase of options or other securities from employees upon the end of their employment with an Issuer Group Entity;
(h) enter into
an agreement with respect to, or consummate, any acquisition (whether by merger, stock purchase, asset purchase or otherwise) of another business or Person requiring the payment of consideration greater than 400% of such business’s or Person’s
EBITDA during the preceding calendar year;
(i) amend,
modify or supplement any existing equity incentive plan or enter into or adopt any new equity incentive plan except to the extent such new plan or supplement does not increase the number of shares issuable pursuant to all equity incentive plans to
more than 10% of the then outstanding Company Shares on a fully-diluted basis or such amendment or modification is, in the reasonable opinion of the Board of Directors of the Issuer after receiving advice of counsel, necessary or advisable to
comply with any change in law;
(j) enter into
any agreement or arrangement that would restrict the Conversant Investor from having or exercising any consent right set forth in this Agreement, that would require any Issuer Group Entity to breach any obligations to the Conversant Investor under
this Agreement, the Note Purchase Agreement, or any applicable Convertible Note and/or that contain any non-competition provisions purporting to bind, limit or restrict any Issuer Group Entity or any of its Affiliates;
(k) make any
material tax decisions, elections or other determinations with respect to any Issuer Group Entity;
(l) dissolve,
liquidate, merge or sell the Issuer or all or substantially all of the assets of the Issuer;
(m) issue, sell
or otherwise Transfer Equity Securities of any Subsidiary of the Issuer to a Person other than the Issuer or a wholly owned Subsidiary or the Issuer;
(n) select or
change the independent auditor of the Issuer to an auditor other than a nationally recognized accounting firm;
(o) make any
changes or modifications to any Issuer Group Entity’s fiscal year; or
(p) agree or
resolve to take any of the actions listed in this Section 5.2.
Section 5.3 Information Rights. The Issuer shall deliver or make available (for clarity, information publicly available on the Issuer’s website or the SEC
website shall be deemed to have been made available) to the Conversant Investor:
(a) no later
than the earlier of (i) 135 days following the end of each fiscal year or (ii) the date on which such statements are required to be provided by any Issuer Group Entity to one or more of its lenders pursuant to any credit agreement or other similar
arrangement, audited consolidated financial statements of the Issuer Group Entities for such fiscal year (including balance sheet, statement of operations and comprehensive income, statement of changes in capital (deficit) and statement of cash
flows), consisting of statements of (i) the consolidated financial condition of the Issuer Group Entities as of the end of such fiscal year and (ii) income and cash flows for such fiscal year, prepared in accordance with GAAP by a
nationally-recognized audit firm;
(b) no later
than 60 days following the end of each fiscal quarter, unaudited quarterly financial statements of the Issuer Group Entities (including balance sheet, statement of operations and comprehensive income and statement of changes in capital (deficit)),
prepared in accordance with GAAP;
(c) no later
than 90 days following the end of each fiscal year and, in any event, at least five Business Days prior to the date of any vote of the Board of Directors to approve the same, the drafts of each of the Issuer’s annual business plan and operating
budget prepared in good faith; and
(d) to the
extent reasonably practicable and legally permissible, written notice as soon as any Issuer Group Entity receives a non-routine letter from any U.S. or non-U.S. securities regulatory body, including the SEC describing its findings from an
examination conducted by such regulator that identifies any material deficiencies, together with a copy of any such letter.
Section 5.4 No Shorting; No Manipulation.
(a) During the
Measurement Period, the Conversant Investor will not, and will cause its Affiliates not to, enter into or effect, directly or indirectly, any short sale, any put or call or other derivative transaction or engage in any similar transaction,
including any constructive sale, short, or put, or any hedging, derivative, or other transaction with the same or similar effect, or enter into any contract, option, or other arrangement in respect thereof, or publicly announce an
intention or plan to engage in any of the foregoing, in each case with respect to the Issuer Shares, any securities convertible into or
exchangeable for Issuer Shares, or any options, warrants, or other rights to acquire Issuer Shares. Without limiting the foregoing, during the Measurement Period, the Conversant Investor will not, and will cause its Affiliates not to, take,
directly or indirectly, any action in bad faith without any reasonable basis designed or intended to stabilize or manipulate the price of the Issuer Shares, or which would reasonably be expected to cause or result in, stabilization or manipulation
of the price of the Issuer Shares.
(b) During the
Measurement Period, the Issuer will not, and will cause its Affiliates not to, enter into or effect, directly or indirectly, any purchase transaction or enter into or effect, directly or indirectly, any put or call or other hedging, derivative or
other transaction or engage in any similar transaction, including any constructive purchase, or publicly announce any intention or plan to engage in any of the foregoing, in each case with respect to the Issuer Shares, any securities convertible
into or exchangeable for Issuer Shares, or any options, warrants or other rights to acquire Issuer Shares. Without limiting the foregoing, during the Measurement Period, the Issuer and its Affiliates will not take, directly or indirectly, any
action in bad faith or allow any trading designed or intended to stabilize or manipulate the price of the Issuer Shares, or which would reasonably be expected to cause or result in, stabilization or manipulation of the price of the Issuer Shares.
ARTICLE VI.
MISCELLANEOUS
Section 6.1 Term and Termination.
(a) This
Agreement shall commence upon the Closing Date and shall terminate automatically upon the later of (i) the one-year anniversary of the Closing Date and (ii) such time as the total of the Issuer Class A Shares and Underlying Shares held by the
Conversant Investor and its Affiliates falls below 5% of the Issuer Shares that would be outstanding if all Convertible Notes held by the Conversant Investor at such time had been converted into Issuer Class A Shares at such time.
(b) In the
event of a termination of this Agreement in accordance with this Section 6.1, no party (or any of its Affiliates) shall have any liability or obligation to the other parties (nor to any of their respective Affiliates) under or in respect of this
Agreement, and all further obligations of the parties under this Agreement will be terminated without further liability of any party to any other party (other than any liabilities arising from actions, omissions or breaches of such party that
occurred prior to such termination).
Section 6.2 Assignment. Except as set forth in the immediately following sentence, neither this Agreement, nor any of the
rights, interests or obligations hereunder shall be assigned or delegated by any of the parties hereto (whether by operation of Law or otherwise) without the prior written consent of the other parties. For so long as the Conversant Investor is
entitled to exercise the rights set forth in this Agreement, the Conversant Investor may assign those rights to Conversant Capital LLC or any Affiliate thereof upon written notice to the Issuer.
Section 6.3 Successors and Assigns. The term and conditions of this Agreement shall inure
to the benefit of and be binding upon the respective successors and assigns of the parties. Nothing in this Agreement, express or implied, is
intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement.
Section 6.4 Governing Law. This Agreement and all controversies arising out of or relating to it (whether based in
contract, tort, or statute) shall in all respects be governed by and construed in accordance with the laws of the State of Delaware, without regard to any choice of law or conflict of law principles or rules (whether of the State of Delaware or any
other jurisdiction) that would result in the application of any law other than the law of the State of Delaware.
Section 6.5 Counterparts. This Agreement may be executed in any number of counterparts (including pdf or any electronic
signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com), each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile,
electronic mail or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.
Section 6.6 Titles and Subtitles. The titles and subtitles in this Agreement are used for convenience only and are not to
be considered in construing or interpreting this Agreement.
Section 6.7 Notices. All notices and other communications given or made pursuant to this Agreement shall be in writing and
shall be deemed effectively given upon the earlier of (a) actual receipt and (b) any of (i) personal delivery to the party to be notified, (ii) when sent, if sent by electronic mail (unless the party sending such communication by electronic mail
receives a hard bounce-back or delivery failure message), or (iii) one (1) Business Day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next Business Day delivery, with written verification of receipt or
refusal. All communications shall be sent to the respective parties at their address as set forth below or on such party’s signature page hereto or to the e‑mail address set forth below or on such party’s signature page hereto as subsequently
modified by written notice given in accordance with this Section 6.7. All notices hereunder shall be delivered as set forth below, or pursuant to such other instructions as may be designated in writing by the party to receive such notice:
|
|
if to the Issuer or any Issuer Group Entity, to: |
|
|
|
|
|
|
|
|
United Homes Group, Inc
90 N Royal Tower Drive
Irmo, South Carolina 29063
|
|
|
|
|
Tom O’Grady, Chief Administrative Officer
Steve Lenker, Executive Vice President and General Counsel
|
|
|
|
Email: |
tomogrady@greatsouthernhomes.com
stevelenker@greatsouthernhomes.com
|
|
|
|
|
|
|
|
with a copy (which shall not constitute notice) to:
|
| |
|
Nelson Mullins Riley & Scarborough LLP
101 Constitution Avenue NW, Suite 900
Washington, DC 20001
|
|
|
|
Attention: |
Andy Tucker
Erin Reeves McGinnis
|
|
|
|
Email: |
andy.tucker@nelsonmullins.com
erin.reevesmcginnis@nelsonmullins.com
|
|
|
|
|
|
|
|
if to the Conversant Investor, to: |
| |
|
|
|
| |
|
c/o Conversant Capital LLC
25 Deforest Avenue
Summit, New Jersey 07901
|
| |
|
Attention: |
Keith O’Connor
|
| |
|
Email: |
ko@conversantcap.com
|
| |
|
|
|
| |
with a copy (which shall not constitute notice) to:
|
| |
|
|
| |
|
Fried, Frank, Harris, Shriver & Jacobson LLP
One New York Plaza
New York, New York 10004-1980
|
| |
|
Attention:
|
John M. Bibona
john.bibona@friedfrank.com
|
Section 6.8 Amendments and Waivers. Except as expressly provided herein, neither this Agreement nor any term hereof may be
amended, waived, discharged or terminated other than by a written instrument referencing this Agreement and signed by each of the Issuer and the Conversant Investor. No failure or delay by any party in exercising any right, power or privilege
hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. No waiver of any party to this Agreement will be
effective unless it is in a writing signed by an officer of the waiving party that makes express reference to the provision or provisions subject to such waiver. The rights and remedies herein provided shall be cumulative and not exclusive of any
rights or remedies provided by law.
Section 6.9 Severability. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or
enforceability of any other provision.
Section 6.10 Delays or Omissions. No delay in exercising or failure to exercise any right, power or remedy accruing to any
party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach
or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any
waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and
shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise
afforded to any party, shall be cumulative and not alternative.
Section 6.11 Entire Agreement. This Agreement, the Note Purchase Agreement, and the Convertible Notes constitute the full
and entire understanding and agreement among the parties with respect to the subject matter thereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled.
Section 6.12 Further Assurances. From and after the date of this Agreement, upon the request of either party hereto, the
other party will execute and deliver such instruments, documents and other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate fully the intent and purposes of this Agreement.
Section 6.13 Jurisdiction and Venue; Waiver of Jury Trial. Each party (a) hereby irrevocably and unconditionally submits to
the exclusive jurisdiction of the Designated Courts or, if no such federal court shall exercise jurisdiction or have subject matter jurisdiction, the Delaware Superior Court, and any appellate court from any appeal thereof, in any suit, action or
other proceeding arising out of or relating to this Agreement, (b) agrees not to commence any suit, action or other proceeding arising out of or relating to this Agreement in any court other than a Designated Court. Each party agrees that a final
judgment in any such suit, action or other proceeding brought before a Designated Court may be enforced in any jurisdiction by suit on the judgment or in any other manner provided by Law. Each party hereby waives, and agrees not to assert, by way
of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the
suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.
EACH PARTY HEREBY WAIVES ITS RIGHT TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS, THE SECURITIES OR
THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING CONTRACT CLAIMS, TORT CLAIMS
(INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY
FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.
Section 6.14 Interpretation. As used in this Agreement, unless the context otherwise requires:
(a) a
capitalized term has the meaning assigned to it;
(b) an
accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP;
(c) references
in the singular or to “him,” “her,” “it,” “itself,” or other like references, and references in the plural or the feminine or masculine reference, as the case may be, shall also, when the context so requires, be deemed to include the plural or
singular, or the masculine or feminine reference, as the case may be;
(d) any statute
defined or referred to herein means such statute as from time to time amended, modified or supplemented;
(e) references
to Articles, Sections and Exhibits shall refer to articles, sections and the exhibit of this Agreement, unless otherwise specified;
(f) the
headings in this Agreement are for convenience and identification only and are not intended to describe, interpret, define or limit the scope, extent or intent of this Agreement or any provision thereof;
(g) this
Agreement shall be construed without regard to any presumption or other rule requiring construction against the party that drafted and caused this Agreement to be drafted;
(h) all
monetary figures shall be in United States dollars unless otherwise specified;
(i) references
to “including” in this Agreement shall mean “including, without limitation,” whether or not so specified;
(j) references
to “ordinary course of business” in this Agreement shall mean “ordinary course of business consistent with past practice,” whether or not so specified;
(k) the word
“extent” in the phrase “to the extent” shall mean the degree to which a subject or other theory extends and such phrase shall not mean “if”;
(l) the
words “herein,” “hereof,” “hereunder,” and words of similar import refer to this Agreement as a whole and not to any particular Article, Section or other subdivision; and
(m) the word
“or” is not exclusive.
[Remainder of page intentionally left blank. Signature pages follow.]
IN WITNESS WHEREOF, the undersigned have executed this Subscription Agreement as of the date first written above.
| |
ISSUER:
|
| |
|
| |
UNITED HOMES GROUP, INC.
|
| |
|
| |
|
| |
By:
|
|
| |
|
Name:
|
| |
|
Title:
|
| |
|
| |
|
| |
|
| |
CONVERSANT INVESTOR:
|
| |
|
| |
CONVERSANT OPPORTUNITY MASTER FUND LP
By: CONVERSANT GP HOLDINGS LLC
Its: General Partner
|
| |
|
| |
|
| |
By:
|
|
| |
|
Name:
|
| |
|
Title:
|